Barclays »

Sanara Medtech shares owned by Barclays

Quarter-by-quarter ownership of Sanara Medtech (SMTI) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Sanara Medtech

Tip: Access up to 7 years of quarterly data

All positions including Sanara Medtech held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sanara Medtech by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $220k 5.3k 41.17
2023-09-30 $22k 683 32.21
2023-06-30 $30k 757 39.63

More positions owned by Barclays

Invesco Qqq Tr Opt Call Option (QQQ)
SPDR S&ampP 500 ETF TR Opt Put Option (SPY)
Microsoft Corp Opt Call Option (MSFT)
Ishares Tr Opt Call Option (IWM)
Apple (AAPL)
Amazon Opt Call Option (AMZN)
Alphabet Opt Put Option (GOOGL)
NVIDIA Corporation (NVDA)
Tesla Opt Put Option (TSLA)
Meta Platforms Opt Put Option (META)
Ishares Tr Fund (HYG)
Alphabet Opt Call Option (GOOG)
Visa Opt Put Option (V)
Broadcom (AVGO)
Berkshire Hathaway (BRK.B)

View all positions for Barclays

Top funds holding Sanara Medtech

Vanguard Group
Janney Montgomery Scott
Bank of New York Mellon
Salem Investment Counselors
Citadel Advisors
Charles Schwab Investment Management
T. Rowe Price Associates
Barclays
UBS Group
Bank of America Corporation
Rhumbline Advisers
Deutsche Bank Aktiengesellschaft
Jpmorgan Chase & Co
Lazard Asset Management
New York State Common Retirement Fund

View all funds holding Sanara Medtech